3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
3
Withdrawn
1
Unknown
1
Completed
1
Sponsor Class
OTHER
20
INDUSTRY
2
UNKNOWN
1
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
66
Neoplasms
47
Stomach Neoplasms
44
Colorectal Neoplasms
42
Carcinoma, Non-Small-Cell Lung
35
Lung Neoplasms
30
Uterine Cervical Neoplasms
28
Rectal Neoplasms
28
Carcinoma, Hepatocellular
25
Prostatic Neoplasms
24
Recurrence
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Ovarian Neoplasms
18
Neoplasm Metastasis
16
Colonic Neoplasms
16
Esophageal Neoplasms
15
Urinary Bladder Neoplasms
14
Thyroid Neoplasms
14
Pancreatic Neoplasms
14
Nasopharyngeal Carcinoma
14
Leukemia, Myeloid, Acute
13
Head and Neck Neoplasms
13
Papillomavirus Infections
11
Multiple Myeloma
11
Motor Activity
11
Lymphoma
11
Small Cell Lung Carcinoma
10
Sarcoma
10
Melanoma
10
Lymphoma, Non-Hodgkin
10
Interventions
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
OTHER_GOV
×
Pathologic Complete Response
×
Clear all
NCT01830244
2017-07-02
Neonab
Barwon Health
Phase 2
Unknown
60 enrolled